ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
37 hedge funds and large institutions have $6.37M invested in Anthera Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
37
Holding in Top 10
–
Calls
$985K
Puts
$111K
Top Buyers
| 1 | +$1.35M | |
| 2 | +$1.32M | |
| 3 | +$476K | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$361K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$60.7K |
Top Sellers
| 1 | -$196K | |
| 2 | -$155K | |
| 3 | -$90.8K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$89.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$85.8K |